These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16434482)

  • 1. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.
    Casey G; Neville PJ; Liu X; Plummer SJ; Cicek MS; Krumroy LM; Curran AP; McGreevy MR; Catalona WJ; Klein EA; Witte JS
    Hum Mol Genet; 2006 Mar; 15(5):735-41. PubMed ID: 16434482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.
    Neville PJ; Conti DV; Paris PL; Levin H; Catalona WJ; Suarez BK; Witte JS; Casey G
    Neoplasia; 2002; 4(5):424-31. PubMed ID: 12192601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
    Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
    J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.
    Liu X; Cheng I; Plummer SJ; Suarez BK; Casey G; Catalona WJ; Witte JS
    Prostate; 2011 May; 71(7):682-9. PubMed ID: 20945404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
    Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
    Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
    Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ
    Prostate; 2003 Dec; 57(4):298-308. PubMed ID: 14601026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
    Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
    Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.
    Cicek MS; Nock NL; Li L; Conti DV; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1331-6. PubMed ID: 15298954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies.
    Neville PJ; Conti DV; Krumroy LM; Catalona WJ; Suarez BK; Witte JS; Casey G
    Genes Chromosomes Cancer; 2003 Apr; 36(4):332-9. PubMed ID: 12619157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
    Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
    Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer.
    Bachmann N; Hoegel J; Haeusler J; Kuefer R; Herkommer K; Paiss T; Vogel W; Maier C
    Prostate; 2005 Nov; 65(3):252-9. PubMed ID: 16015586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.
    Freedman ML; Haiman CA; Patterson N; McDonald GJ; Tandon A; Waliszewska A; Penney K; Steen RG; Ardlie K; John EM; Oakley-Girvan I; Whittemore AS; Cooney KA; Ingles SA; Altshuler D; Henderson BE; Reich D
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14068-73. PubMed ID: 16945910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
    Paris PL; Kupelian PA; Hall JM; Williams TL; Levin H; Klein EA; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):901-5. PubMed ID: 10548319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
    Ross PL; Cheng I; Liu X; Cicek MS; Carroll PR; Casey G; Witte JS
    BMC Cancer; 2009 Feb; 9():69. PubMed ID: 19245716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
    Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
    J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
    Xu J; Zheng SL; Komiya A; Mychaleckyj JC; Isaacs SD; Hu JJ; Sterling D; Lange EM; Hawkins GA; Turner A; Ewing CM; Faith DA; Johnson JR; Suzuki H; Bujnovszky P; Wiley KE; DeMarzo AM; Bova GS; Chang B; Hall MC; McCullough DL; Partin AW; Kassabian VS; Carpten JD; Bailey-Wilson JE; Trent JM; Ohar J; Bleecker ER; Walsh PC; Isaacs WB; Meyers DA
    Nat Genet; 2002 Oct; 32(2):321-5. PubMed ID: 12244320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.